A Role for Endothelin-2 and Its Receptors in Breast Tumor Cell Invasion

Cancer Research

Volumn 64, Issue 7, 2004, Pages 2461-2468

  Grimshaw, Matthew J ^a,d   Hagemann, Thorsten ^b   Ayhan, Ayse ^c   Gillett, Cheryl E ^d   Binder, Claudia ^b   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c HACETTEPE UNIVERSITY   (Turkey)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; GELATINASE A; GELATINASE B; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SECONDARY LYMPHOID TISSUE CHEMOKINE; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CELL HYPOXIA; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; CELL LINE, TUMOR; CHEMOTAXIS; COCULTURE TECHNIQUES; ENDOTHELIN-1; ENDOTHELIN-2; HUMANS; ISOENZYMES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER;

EID: 1942538390     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1069     Document Type: Article

References (32)

1. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
2. Masaki T. The endothelin family: an overview. J Cardiovasc Pharmacol 2000;35: S3-5.
3. Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J 1995;9:1196-204.
4. Haendler B, Hechler U, Schleuning WD. Molecular cloning of human endothelin (ET) receptors ETA and ETB. J Cardiovasc Pharmacol 1992;20:S1-4.
5. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003;3:110-6.
6. Grimshaw MJ, Naylor S, Balkwill FR. Endothelin-2 Is a Hypoxia-induced autocrine survival factor for breast tumor cells. Mol Cancer Ther 2002;1:1273-81.
7. Ishikawa K, Ihara M, Noguchi K, et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994;91:4892-6.
8. Ihara M, Noguchi K, Saeki T, et al. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992;50:247-55.
9. Ueno T, Toi M, Saji H, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000;6:3282-9.
10. Dachs GU, Tozer GM. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 2000;36:1649-60.
11. Grimshaw MJ, Wilson JL, Balkwill FR. Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 2002;32: 2393-400.
12. Peacock AJ, Dawes KE, Shock A, Gray AJ, Reeves JT, Laurent GJ. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 1992;7:492-9.
13. Elferink JG, de Koster BM. Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c. Chem Biol Interact 1996;101:165-74.
14. Rosano L, Varmi M, Salani D, et al. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 2001;61:8340-6.
15. Berry P, Burchill S. Endothelins may modulate invasion and proliferation of Ewing's sarcoma and neuroblastoma. Clin Sci (Lond) 2002;103 Suppl 48:S322-6.
16. Ihara M, Ishikawa K, Fukuroda T, et al. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 1992;20 Suppl 12:S11-4.
17. Dias S, Boyd R, Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer 1998;78:361-5.
18. Traish AM, Moran E, Daley JT, de las Morenas A, Saenz de Tejada I. Monoclonal antibodies to human endothelin-1: characterization and utilization in radioimmunoassay and immunocytochemistry. Hybridoma 1992;11:147-63.
19. Furuya S, Hiroe T, Ogiso N, Ozaki T, Hori S. Localization of endothelin-A and -B receptors during the postnatal development of rat cerebellum. Cell Tissue Res 2001;305:307-24.
20. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
21. Heinroth-Hoffmann I, Vogelsang M, Schiewe P, et al. Mechanism of ET(A)-receptor stimulation-induced increases in intracellular Ca2+ in SK-N-MC cells. Br J Pharmacol 1998;125:1202-11.
22. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.) 2001;410:50-6.
23. Guise TA, Yin JJ, Mohammad KS. Role of endothelin-1 in osteoblastic bone metastases. Cancer (Phila.) 2003;97:779-84.
24. 2 tension measurements. Cancer Res 1991;51:3316-22.
25. 2-histography. Adv Exp Med Biol 1994;345:451-8.
26. Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin Surg Oncol 1993;9:256-63.
27. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998;95:11715-20.
28. Bagnato A, Spinella F. Emerging role of endothelin-1 in tumor angiogenesis. Trends Endocrinol Metab 2002;14:44-50.
29. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002;283:R7-28.
30. Grimshaw MJ, Balkwill FR. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation-a potential mechanism. Eur J Immunol 2001;31:480-9.
31. Norman P. Atrasentan Abbott. Curr Opin Investig Drugs 2002;3:1240-8.
32. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999;80:617-23.